Cargando…
CAR T-Cell Therapy: On the Verge of Breakthrough in Many Hematologic Malignancies
There have been promising results from clinical trials on the efficacy of engineering patients’ immune cells to treat their cancers. CAR T-cell therapy also has unique toxicities advanced practitioners should be aware of.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Harborside Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003752/ https://www.ncbi.nlm.nih.gov/pubmed/29928544 |